Amado Rivero - Publications

Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 21, 2025

Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: March 08, 2024

Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 24, 2023

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: December 11, 2022

Factors that Influence Treatment Delay for Patients with Breast Cancer.

Journal: Annals of surgical oncology

Published: July 17, 2020

Health services research in patients with breast cancer (CAMISS-prospective): study protocol for an observational prospective study.

Journal: BMC cancer

Published: July 07, 2017

Papain-treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti-CD38-based therapies.

Journal: Transfusion medicine (Oxford, England)

Published: June 20, 2017